Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Quanterix Corp (QTRX)
Sector: Healthcare; Industry: Medical Devices

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-10-01 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 3,286 $34.12 $112,126 No
2020-10-01 Roskey Mark T. SVP, Commercial & Accelerator Sell 92 $34.12 $3,139 No
2020-10-01 Chaubal Amol Chief Financial Officer Sell 116 $34.12 $3,958 No
2020-09-29 Madaus Martin D Director Sell 3,200 $32.80 $104,969 Yes
2020-09-24 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 2,000 $32.26 $64,520 No
2020-09-17 Madaus Martin D Director Sell 3,200 $32.80 $104,944 Yes
2020-09-17 Duffy David C. SVP R&D and CTO Sell 1,667 $32.43 $54,061 No
2020-09-15 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 3,500 $33.15 $116,037 No
2020-09-01 Roskey Mark T. SVP, Commercial & Accelerator Sell 95 $34.91 $3,317 No
2020-09-01 Chaubal Amol Chief Financial Officer Sell 120 $34.91 $4,189 No
2020-09-01 Fry John J General Counsel & Secretary Sell 148 $34.91 $5,167 No
2020-09-01 Mattoon Dawn Sr. VP, Research Products Sell 165 $34.91 $5,760 No
2020-09-01 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 3,390 $34.91 $118,349 No
2020-09-02 Madaus Martin D Director Sell 3,200 $35.23 $112,720 Yes
2020-08-25 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 3,500 $35.28 $123,468 No
2020-08-19 Duffy David C. SVP R&D and CTO Sell 1,680 $34.92 $58,666 No
2020-08-19 Madaus Martin D Director Sell 3,200 $34.72 $111,104 Yes
2020-08-14 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 3,500 $36.72 $128,533 No
2020-08-07 DEKKERS MARIJN E Director Sell 27,619 $32.49 $897,341 No
2020-08-03 Mattoon Dawn Sr. VP, Research Products Sell 156 $32.26 $5,032 No
2020-08-03 Roskey Mark T. SVP, Commercial & Accelerator Sell 90 $32.25 $2,903 No
2020-08-05 Madaus Martin D Director Sell 3,200 $32.89 $105,248 Yes
2020-08-03 Chaubal Amol Chief Financial Officer Sell 114 $32.26 $3,677 No
2020-08-04 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 7,230 $32.17 $232,625 No
2020-08-03 Fry John J General Counsel & Secretary Sell 141 $32.25 $4,548 No
2020-07-21 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 2,636 $31.87 $84,016 No
2020-07-21 Madaus Martin D Director Sell 3,200 $31.25 $100,000 Yes
2020-07-16 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 4,500 $27.94 $125,730 No
2020-07-13 Duffy David C. SVP R&D and CTO Sell 1,667 $27.39 $45,659 No
2020-07-09 Madaus Martin D Director Sell 3,200 $26.93 $86,160 Yes

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

Upwork Inc (UPWK) - GRETSCH GREGORY C. Director of Upwork, made a bulk buy of 500K shares right before the big gap up, which is also the largest buy of the past 12 months.